The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals.

The Food and Drug Administration says there are too many unknowns about CBD products to regulate them as foods or supplements.

The U.S. is expanding COVID-19 boosters, opening a third dose of Pfizer's vaccine to people as young as age 16.

President Joe Biden is nominating former Food and Drug Administration commissioner Dr. Robert Califf to again lead the powerful regulatory agency.

The acting head of the Food and Drug Administration is calling for a government investigation into highly unusual contacts between her agency’s drug reviewers and the maker of a controversial new Alzheimer’s drug.

Children ages 12 and older can now get COVID-19 vaccines in the U.S., offering parents and schools a chance to relax their pandemic precautions.

U.S. health regulators are pledging again to try to ban menthol cigarettes.

Montana Gov. Greg Gianforte has issued an executive order banning the development or use of vaccine passports in Montana.

Hong Kong and Singapore say they have agreed to a bilateral air travel bubble, re-establishing travel links as coronavirus infections in both cities decline. -- Maryland will reduce indoor operations for bars and restaurants from 75% to 50% in response to rising coronavirus cases and increased hospitalizations. Maryland also reported 1,338 new coronavirus cases Tuesday — the seventh straight day of at least 1,000 cases. ___WASHINGTON — The U.S. has surpassed 1 million new confirmed coronavirus cases since the start of November. The El Paso County sheriff’s office says two of the employees were hospitalized over the weekend as coronavirus cases surged at the facility.

Since last year, the FDA has been investigating NDMA and other impurities in blood pressure and heart failure medicines known as angiotensin receptor blockers or ARBs. Numerous recalls have been launched as the FDA found "unacceptable levels" of nitrosamines in several of those common drugs containing valsartan. So far, NDMA has been found in ranitidine in low levels and we are not calling for consumers and patients to stop taking ranitidine at this time," he said. The FDA will share more information with the public and industry as we learn more throughout the investigation." Woodcock said the FDA is working with international regulators and industry partners to determine the source of the ranitidine impurity.